SCHEMBL12649999

SCHEMBL12649999

CC(=O)OCC1OC(c2ccc(Cl)c(CO)c2)[C@H](OC(C)=O)C(OC(C)=O)C1OC(C)=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.64
PTPN1 P18031 1/20 0.50
CA12 O43570 12/20 0.45
CA1 P00915 12/20 0.45
CA2 P00918 12/20 0.45
CA4 P22748 11/20 0.45
CA5A P35218 11/20 0.45
CA7 P43166 11/20 0.45
CA5B Q9Y2D0 11/20 0.45
CA9 Q16790 6/20 0.45
CA6 P23280 4/20 0.45
CA13 Q8N1Q1 4/20 0.45
CA14 Q9ULX7 4/20 0.45
CYP2D6 P10635 1/20 0.45
THRB P10828 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12601659 1.00 TSHR (0.64) TSHRPTPN1CA12CA1CA2
SCHEMBL222652 1.00 TSHR (0.64) TSHRPTPN1CA12CA1CA2
SCHEMBL12334423 1.00 TSHR (0.64) TSHRPTPN1CA12CA1CA2
SCHEMBL15368881 1.00 TSHR (0.64) TSHRPTPN1CA12CA1CA2
SCHEMBL2469148 1.00 TSHR (0.64) TSHRPTPN1CA12CA1CA2
SCHEMBL14081703 0.91 TSHR (0.58) TSHRPTPN1
SCHEMBL19415621 0.90 TSHR (0.63) TSHRPTPN1CA12CA1CA2
SCHEMBL19415672 0.90 TSHR (0.63) TSHRPTPN1CA12CA1CA2
SCHEMBL14248547 0.90 TSHR (0.63) TSHRPTPN1CA12CA1CA2
SCHEMBL2865475 0.90 TSHR (0.63) TSHRPTPN1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943788-B2 Including the antidiabetic, antiobesity sodium glucose transport inhibitor Canagliflozin (1-( beta -D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene) MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-05-17 US disclosed